|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 333.85 USD | -0.84% |
|
-3.79% | +35.41% |
| 09-08 | Krystal Biotech Insider Sold Shares Worth $8,983,084, According to a Recent SEC Filing | MT |
| 09-08 | Krystal Biotech Insider Sold Shares Worth $8,982,986, According to a Recent SEC Filing | MT |
| Market Cap | 9.88B 8.62B 8.11B 7.39B 13.86B 947B 13.88B 97.2B 37.44B 482B 37.12B 36.29B 1,555B | P/E 2026 * |
44x | P/E 2027 * | 35.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.88B 8.62B 8.11B 7.39B 13.86B 947B 13.88B 97.2B 37.44B 482B 37.12B 36.29B 1,555B | EV / Sales 2026 * |
19.3x | EV / Sales 2027 * | 15.1x |
| Free-Float |
89.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KRYS | Delayed | |
CBOE
| KRYS | Real-time | |
|
Tradegate
| 4KB | Real-time | |
|
Boerse Muenchen
| 4KB | Real-time | |
|
Deutsche Boerse AG
| 4KB | Delayed | |
|
Börse Stuttgart
| 4KB | Delayed | |
|
Borsa Italiana
| 1KRYS | End-of-day quote | |
|
Xetra
| 4KB | Delayed |
Last Transcript: Krystal Biotech, Inc.
| 1 day | -0.84% | ||
| 1 week | -3.79% | ||
| Current month | -7.10% | ||
| 1 month | -0.94% | ||
| 3 months | -4.08% | ||
| 6 months | +32.65% | ||
| Current year | +35.41% |
| 1 week | 331.79 |  | 346.2 |
| 1 month | 331.79 | | 373.31 |
| Current year | 235.6 | | 382.54 |
| 1 year | 158.08 | | 382.54 |
| 3 years | 93.95 | | 382.54 |
| 5 years | 38.86 | | 382.54 |
| 10 years | 8.03 | | 382.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 2016-04-14 |
| Chief Executive Officer | 61 | 2016-04-14 | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2016-04-14 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 2016-04-14 |
Daniel Janney
BRD | Director/Board Member | 60 | 2016-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/14/26 | Free | Director | 1,658 | 0.0056% | ||
| 9/14/26 | Free | Director | 1,658 | 0.0056% | ||
| 9/14/26 | Free | Director | 1,658 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.84% | -3.79% | +104.10% | +185.73% | 9.97B | |
| +1.70% | +2.13% | +34.83% | -4.02% | 78.37B | |
| +12.27% | +20.12% | +585.18% | +67.04% | 61.5B | |
| +1.54% | +6.70% | -10.12% | -32.11% | 59.78B | |
| +0.29% | -0.92% | -10.95% | +26.82% | 46.53B | |
| +1.92% | +3.16% | +4.33% | +150.18% | 45.5B | |
| +1.66% | +0.88% | +53.73% | -15.91% | 31.84B | |
| -0.53% | +2.62% | +44.05% | +106.48% | 25.4B | |
| +6.00% | +9.46% | +11.24% | +166.67% | 21.43B | |
| -0.76% | +1.19% | +57.98% | +102.93% | 15.77B | |
| Average | +1.14% | +1.26% | +87.44% | +75.38% | 39.61B | |
| Weighted average by Cap. | +1.26% | +1.55% | +108.11% | +48.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 513M 447M 421M 383M 719M 49.11B 720M 5.04B 1.94B 25.02B 1.93B 1.88B 80.65B | 655M 571M 537M 490M 918M 62.71B 919M 6.44B 2.48B 31.95B 2.46B 2.4B 103B |
| Net income | 237M 207M 195M 178M 333M 22.74B 333M 2.33B 899M 11.59B 892M 872M 37.35B | 303M 265M 249M 227M 426M 29.06B 426M 2.98B 1.15B 14.8B 1.14B 1.11B 47.72B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | US$333.85 | -0.84% | 210,244 |
| 26-09-18 | US$336.67 | -0.61% | 1,003,947 |
| 26-09-17 | US$338.75 | +0.62% | 280,929 |
| 26-09-16 | US$336.67 | -0.00% | 251,878 |
| 26-09-15 | US$336.68 | -0.99% | 225,818 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
